Back

Deciphering the state of immune silence in fatal COVID-19 patients

2020-08-13 infectious diseases Title + abstract only
View on medRxiv
Show abstract

Since the beginning of the SARS-CoV-2 pandemic, COVID-19 has appeared as a unique disease with unconventional tissue and systemic immune features. While COVID-19 severe forms share clinical and laboratory aspects with various pathologies such as hemophagocytic lymphohistiocytosis, sepsis or cytokine release syndrome, their exact nature remains unknown. This is severely impeding the ability to treat patients facing severe stages of the disease. To this aim, we performed an in-depth, single-cell R...

Predicted journal destinations

1
Nature Communications
483 training papers
Top 1% 22.0%
2
Frontiers in Immunology
140 training papers
Top 0.9% 8.9%
3
Cell Reports Medicine
49 training papers
#1 6.4%
4
iScience
74 training papers
#1 6.4%
5
JCI Insight
63 training papers
Top 0.6% 5.9%
6
Nature Medicine
88 training papers
Top 0.2% 5.0%
7
Scientific Reports
701 training papers
Top 56% 5.0%
8
eLife
262 training papers
Top 16% 2.8%
9
Nature
58 training papers
Top 0.6% 2.8%
10
Cell
28 training papers
Top 0.5% 1.9%
11
Science Translational Medicine
40 training papers
Top 0.7% 1.9%
12
Journal of Clinical Investigation
50 training papers
Top 2% 1.9%
13
Clinical Infectious Diseases
219 training papers
Top 17% 1.5%
14
The Journal of Infectious Diseases
137 training papers
Top 9% 1.5%
15
PLOS Pathogens
35 training papers
Top 0.6% 1.5%
16
eBioMedicine
82 training papers
Top 3% 1.5%
17
Viruses
79 training papers
Top 4% 1.5%
18
mBio
34 training papers
Top 1.0% 1.3%
19
Journal of Medical Virology
95 training papers
Top 10% 1.2%
20
Science Immunology
15 training papers
Top 0.6% 1.1%
21
PLOS ONE
1737 training papers
Top 98% 1.0%
22
Cell Reports
25 training papers
Top 2% 0.9%
23
Proceedings of the National Academy of Sciences
100 training papers
Top 20% 0.7%
24
Frontiers in Medicine
99 training papers
Top 24% 0.7%
25
Genome Medicine
56 training papers
Top 8% 0.7%
26
Science
46 training papers
Top 7% 0.7%